 | Issue navigator |
|
|
Contents of Volume 9 Suppl 5
Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
Reviews
Edited by John B Holcomb
Supported by an educational grant from Novo Nordisk
|
Review
 
The epidemiology and modern management of traumatic hemorrhage: US and international perspectives
David S Kauvar, Charles E Wade
Critical Care 2005, 9(Suppl 5):S1-S9 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Review
Optimizing the use of blood products in trauma care
John R Hess, Seppo Hiippala
Critical Care 2005, 9(Suppl 5):S10-S14 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles]
Review
Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma
Anthony E Pusateri, Myung S Park
Critical Care 2005, 9(Suppl 5):S15-S24 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Review
Preclinical trauma studies of recombinant factor VIIa
Martin A Schreiber, John B Holcomb, Rasmus Rojkjaer
Critical Care 2005, 9(Suppl 5):S25-S28 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles]
Review
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings
R Michael Grounds, Charles Bolan
Critical Care 2005, 9(Suppl 5):S29-S36 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
Review
Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma
Alicia M Mohr, John B Holcomb, Richard P Dutton, Jacques Duranteau
Critical Care 2005, 9(Suppl 5):S37-S42 (7 October 2005)
[Full text] [PDF] [PubMed] [Related articles]
| |
|  |
